It’s bad enough when the cure is worse than the disease, but what about when the cure becomes the disease? That seems to be what is happening with Molnupiravir, Merck’s antiviral therapeutic which it has made billions selling to a world terrified by the SARS-CoV-2 virus.
A widely used COVID-19 drug may be driving the appearance of new SARS-CoV-2 variants, sparking concerns it could prolong and even reinvigorate the pandemic. The drug, molnupiravir, produced by Merck & Co., is designed to kill the virus by inducing mutations in the viral genome. A survey of viral genomes reported in a new preprint, however, suggests some people treated with the drug generate novel viruses that not only remain viable, but spread.
The abstract from the preprint sums the situation up with this anodyne yet chilling sentence:
Our data suggest a signature of molnupiravir mutagenesis can be seen in global sequencing databases, in some cases with onwards transmission.
The drug meant to stop disease is creating new diseases, if the preprint is accurate.
Houston, we have a BIG problem here!
The exchange of money for evil is epic. Without bounds.
Seems like a feature, not a bug.
Someone told me about this study earlier today. This was something I've mentioned previously, and the FDA has even brought up concerns that this would happen and mentioned that Merck had to collect data to see if this would happen. The committee was really concerned about this issue to the point that a few recommended patients taking Molnupiravir should isolate from their family in case of mutations...